Trial: 201708029

A Multi-Institutional Phase 2 Study of Nivolumab in Refractory Metastatic Squamous Cell Carcinoma of the Anal Canal

Phase

II

Principal Investigator

Aranha, Olivia

Disease Site

Anus

Learn more about this study at: clinicaltrials.gov